查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
不孕治療服務的全球市場:市場佔有率及排行榜·整體銷售額及需求預測 (2024-2030年)
市場調查報告書
商品編碼
1421034

不孕治療服務的全球市場:市場佔有率及排行榜·整體銷售額及需求預測 (2024-2030年)

Infertility Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
出版日期: | 出版商: QYResearch | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球不孕治療服務市場規模預計將從 2023 年的 71.9114 億美元增長到 2030 年的 118.2164 億美元，預測期內複合年增長率為 7.41%。

北美市場預計將從 2023 年的 23.177 億美元增至 2030 年的 38.344 億美元，預測期內複合年增長率為 7.39%。亞太市場預計將從 2023 年的 32.1156 億美元增至 2030 年的 54.5441 億美元，同期複合年增長率為 8%。歐洲市場預計到2030年將達到217,109萬美元，複合年增長率為6.43%，較2023年的14,0515萬美元增長。

本報告提供全球不孕治療服務的市場調查，彙整市場及產品概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各類型·用途的明細，地區·各主要國家的詳細分析，競爭環境，市場佔有率，排行榜，主要企業簡介等資訊。

目錄

第1章 市場概要

  • 不孕治療服務:產品概要
  • 世界市場規模:預測
  • 市場趨勢與推動因素
    • 產業趨勢
    • 推動市場要素和機會
    • 市場課題
    • 阻礙市場要素
  • 前提·限制
  • 調查目的
  • 調查年數

第2章 競爭分析:各企業

  • 企業的收益排行榜
  • 收益:各企業
  • 主要製造商:製造地及總公司
  • 主要製造商:提供產品
  • 競爭分析
  • M&A·擴張

第3章 各類型市場區隔

  • 各類型概要
    • 輔助生殖技術醫療 (ART)
    • 不孕治療藥服務
    • 其他
  • 銷售額
    • 銷售額:2019 vs 2023 vs 2030
    • 銷售額的轉變·預測
    • 銷售額的轉變·預測 (%)

第4章 各用途市場區隔

  • 各用途概要
  • 銷售額
    • 銷售額:2019 vs 2023 vs 2030
    • 銷售額的轉變·預測
    • 銷售額的轉變·預測 (%)

第5章 各地區市場區隔

  • 銷售額
    • 銷售額:2019 vs 2023 vs 2030
    • 銷售額的轉變·預測
    • 銷售額的轉變·預測 (%)
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 主要各國各地區市場區隔

  • 銷售額的成長趨勢:2019 vs 2023 vs 2030
  • 主要國家/地區的銷售額
  • 美國
  • 歐洲
  • 中國
  • 日本
  • 韓國
  • 東南亞
  • 印度

第7章 企業簡介

  • Ferring Pharmaceuticals
  • Merck
  • Jinxin Fertility
  • Vitrolife
  • Mayo Clinic
  • LIVZON
  • Abbott
  • Monash IVF
  • CARE facility
  • Theramex
  • TriHealth
  • NMC Health
  • CooperSurgical
  • Irvine Scientific
  • Virtus Health
  • CinnaGen
  • OB GYN Associates
  • Caerus Biotech
  • InVitroCare
  • INVO Bioscience

第8章 產業鏈分析

  • 產業鏈
  • 上游分析
  • 中游分析
  • 下游分析 (客戶分析)

第9章 調查結果·總論

第10章 附錄

The global market for Infertility Services was estimated to be worth US$ 7,191.14 million in 2023 and is forecast to a readjusted size of US$ 11,821.64 million by 2030 with a CAGR of 7.41% during the forecast period 2024-2030.

North American market for Infertility Services was valued at $ 2,317.7 million in 2023 and will reach $ 3,834.4 million by 2030, at a CAGR of 7.39% during the forecast period of 2024 through 2030.

Asia-Pacific market for Infertility Services was valued at $ 3,211.56 million in 2023 and will reach $ 5,454.41 million by 2030, at a CAGR of 8% during the forecast period of 2024 through 2030.

Europe market for Infertility Services was valued at $ 1,405.15 million in 2023 and will reach $ 2,171.09 million by 2030, at a CAGR of 6.43% during the forecast period of 2024 through 2030.

The global key companies of Infertility Services include: Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, Jinxin Fertility, LIVZON, and Abbott, etc. In 2023, the global five largest players hold a share approximately 23.32% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Infertility Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infertility Services by region & country, by Type, and by Application.

The Infertility Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infertility Services.

Market Segmentation

By Company

  • Ferring Pharmaceuticals
  • Merck
  • Jinxin Fertility
  • Vitrolife
  • Mayo Clinic
  • LIVZON
  • Abbott
  • Monash IVF
  • CARE Facility
  • Theramex
  • TriHealth
  • NMC Health
  • CooperSurgical
  • Irvine Scientific
  • Virtus Health
  • CinnaGen
  • OB GYN Associates
  • Caerus Biotech
  • InVitroCare
  • INVO Bioscience

Segment by Type

  • Assisted Reproductive Technology (ART)
  • Infertility Drug Services
  • Others

Segment by Application

  • Male
  • Female

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Mexico
    • Brazil
    • Rest of South America
  • Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Infertility Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Infertility Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Infertility Services in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Infertility Services Product Introduction
  • 1.2 Global Infertility Services Market Size Forecast (2019-2030)
  • 1.3 Infertility Services Market Trends & Drivers
    • 1.3.1 Infertility Services Industry Trends
    • 1.3.2 Infertility Services Market Drivers & Opportunity
    • 1.3.3 Infertility Services Market Challenges
    • 1.3.4 Infertility Services Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Infertility Services Players Revenue Ranking (2023)
  • 2.2 Global Infertility Services Revenue by Company (2019-2024)
  • 2.3 Key Companies Infertility Services Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Infertility Services Product Offered
  • 2.5 Infertility Services Market Competitive Analysis
    • 2.5.1 Infertility Services Market Concentration Rate (2019-2024)
    • 2.5.2 Global 5 and 10 Largest Companies by Infertility Services Revenue in 2023
    • 2.5.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infertility Services as of 2023)
  • 2.6 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Assisted Reproductive Technology (ART)
    • 3.1.2 Infertility Drug Services
    • 3.1.3 Others
  • 3.2 Global Infertility Services Sales Value by Type
    • 3.2.1 Global Infertility Services Sales Value by Type (2019 VS 2023 VS 2030)
    • 3.2.2 Global Infertility Services Sales Value, by Type (2019-2030)
    • 3.2.3 Global Infertility Services Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

  • 4.1 Introduction by Application
  • 4.2 Global Infertility Services Sales Value by Application
    • 4.2.1 Global Infertility Services Sales Value by Application (2019 VS 2023 VS 2030)
    • 4.2.2 Global Infertility Services Sales Value, by Application (2019-2030)
    • 4.2.3 Global Infertility Services Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

  • 5.1 Global Infertility Services Sales Value by Region
    • 5.1.1 Global Infertility Services Sales Value by Region: 2019 VS 2023 VS 2030
    • 5.1.2 Global Infertility Services Sales Value by Region (2019-2024)
    • 5.1.3 Global Infertility Services Sales Value by Region (2025-2030)
    • 5.1.4 Global Infertility Services Sales Value by Region (%), (2019-2030)
  • 5.2 North America
    • 5.2.1 North America Infertility Services Sales Value, 2019-2030
    • 5.2.2 North America Infertility Services Sales Value by Country (%), 2023 VS 2030
  • 5.3 Europe
    • 5.3.1 Europe Infertility Services Sales Value, 2019-2030
    • 5.3.2 Europe Infertility Services Sales Value by Country (%), 2023 VS 2030
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Infertility Services Sales Value, 2019-2030
    • 5.4.2 Asia Pacific Infertility Services Sales Value by Region (%), 2023 VS 2030
  • 5.5 South America
    • 5.5.1 South America Infertility Services Sales Value, 2019-2030
    • 5.5.2 South America Infertility Services Sales Value by Country (%), 2023 VS 2030
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Infertility Services Sales Value, 2019-2030
    • 5.6.2 Middle East & Africa Infertility Services Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Infertility Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
  • 6.2 Key Countries/Regions Infertility Services Sales Value, 2019-2030
  • 6.3 United States
    • 6.3.1 United States Infertility Services Sales Value, 2019-2030
    • 6.3.2 United States Infertility Services Sales Value by Type (%), 2023 VS 2030
    • 6.3.3 United States Infertility Services Sales Value by Application, 2023 VS 2030
  • 6.4 Europe
    • 6.4.1 Europe Infertility Services Sales Value, 2019-2030
    • 6.4.2 Europe Infertility Services Sales Value by Type (%), 2023 VS 2030
    • 6.4.3 Europe Infertility Services Sales Value by Application, 2023 VS 2030
  • 6.5 China
    • 6.5.1 China Infertility Services Sales Value, 2019-2030
    • 6.5.2 China Infertility Services Sales Value by Type (%), 2023 VS 2030
    • 6.5.3 China Infertility Services Sales Value by Application, 2023 VS 2030
  • 6.6 Japan
    • 6.6.1 Japan Infertility Services Sales Value, 2019-2030
    • 6.6.2 Japan Infertility Services Sales Value by Type (%), 2023 VS 2030
    • 6.6.3 Japan Infertility Services Sales Value by Application, 2023 VS 2030
  • 6.7 South Korea
    • 6.7.1 South Korea Infertility Services Sales Value, 2019-2030
    • 6.7.2 South Korea Infertility Services Sales Value by Type (%), 2023 VS 2030
    • 6.7.3 South Korea Infertility Services Sales Value by Application, 2023 VS 2030
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Infertility Services Sales Value, 2019-2030
    • 6.8.2 Southeast Asia Infertility Services Sales Value by Type (%), 2023 VS 2030
    • 6.8.3 Southeast Asia Infertility Services Sales Value by Application, 2023 VS 2030
  • 6.9 India
    • 6.9.1 India Infertility Services Sales Value, 2019-2030
    • 6.9.2 India Infertility Services Sales Value by Type (%), 2023 VS 2030
    • 6.9.3 India Infertility Services Sales Value by Application, 2023 VS 2030

7 Company Profiles

  • 7.1 Ferring Pharmaceuticals
    • 7.1.1 Ferring Pharmaceuticals Profile
    • 7.1.2 Ferring Pharmaceuticals Main Business
    • 7.1.3 Ferring Pharmaceuticals Infertility Services Products, Services and Solutions
    • 7.1.4 Ferring Pharmaceuticals Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.2 Merck
    • 7.2.1 Merck Profile
    • 7.2.2 Merck Main Business
    • 7.2.3 Merck Infertility Services Products, Services and Solutions
    • 7.2.4 Merck Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.3 Jinxin Fertility
    • 7.3.1 Jinxin Fertility Profile
    • 7.3.2 Jinxin Fertility Main Business
    • 7.3.3 Jinxin Fertility Infertility Services Products, Services and Solutions
    • 7.3.4 Jinxin Fertility Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.4 Vitrolife
    • 7.4.1 Vitrolife Profile
    • 7.4.2 Vitrolife Main Business
    • 7.4.3 Vitrolife Infertility Services Products, Services and Solutions
    • 7.4.4 Vitrolife Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.5 Mayo Clinic
    • 7.5.1 Mayo Clinic Profile
    • 7.5.2 Mayo Clinic Main Business
    • 7.5.3 Mayo Clinic Infertility Services Products, Services and Solutions
    • 7.5.4 Mayo Clinic Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.6 LIVZON
    • 7.6.1 LIVZON Profile
    • 7.6.2 LIVZON Main Business
    • 7.6.3 LIVZON Infertility Services Products, Services and Solutions
    • 7.6.4 LIVZON Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.7 Abbott
    • 7.7.1 Abbott Profile
    • 7.7.2 Abbott Main Business
    • 7.7.3 Abbott Infertility Services Products, Services and Solutions
    • 7.7.4 Abbott Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.8 Monash IVF
    • 7.8.1 Monash IVF Profile
    • 7.8.2 Monash IVF Main Business
    • 7.8.3 Monash IVF Infertility Services Products, Services and Solutions
    • 7.8.4 Monash IVF Infertility Services Revenue (US$ Million) & (2019-2024)
    • 7.8.5 Monash IVF Recent Developments
  • 7.9 CARE facility
    • 7.9.1 CARE facility Profile
    • 7.9.2 CARE facility Main Business
    • 7.9.3 CARE facility Infertility Services Products, Services and Solutions
    • 7.9.4 CARE facility Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.10 Theramex
    • 7.10.1 Theramex Profile
    • 7.10.2 Theramex Main Business
    • 7.10.3 Theramex Infertility Services Products, Services and Solutions
    • 7.10.4 Theramex Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.11 TriHealth
    • 7.11.1 TriHealth Profile
    • 7.11.2 TriHealth Main Business
    • 7.11.3 TriHealth Infertility Services Products, Services and Solutions
    • 7.11.4 TriHealth Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.12 NMC Health
    • 7.12.1 NMC Health Profile
    • 7.12.2 NMC Health Main Business
    • 7.12.3 NMC Health Infertility Services Products, Services and Solutions
    • 7.12.4 NMC Health Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.13 CooperSurgical
    • 7.13.1 CooperSurgical Profile
    • 7.13.2 CooperSurgical Main Business
    • 7.13.3 CooperSurgical Infertility Services Products, Services and Solutions
    • 7.13.4 CooperSurgical Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.14 Irvine Scientific
    • 7.14.1 Irvine Scientific Profile
    • 7.14.2 Irvine Scientific Main Business
    • 7.14.3 Irvine Scientific Infertility Services Products, Services and Solutions
    • 7.14.4 Irvine Scientific Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.15 Virtus Health
    • 7.15.1 Virtus Health Profile
    • 7.15.2 Virtus Health Main Business
    • 7.15.3 Virtus Health Infertility Services Products, Services and Solutions
    • 7.15.4 Virtus Health Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.16 CinnaGen
    • 7.16.1 CinnaGen Profile
    • 7.16.2 CinnaGen Main Business
    • 7.16.3 CinnaGen Infertility Services Products, Services and Solutions
    • 7.16.4 CinnaGen Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.17 OB GYN Associates
    • 7.17.1 OB GYN Associates Profile
    • 7.17.2 OB GYN Associates Main Business
    • 7.17.3 OB GYN Associates Infertility Services Products, Services and Solutions
    • 7.17.4 OB GYN Associates Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.18 Caerus Biotech
    • 7.18.1 Caerus Biotech Profile
    • 7.18.2 Caerus Biotech Main Business
    • 7.18.3 Caerus Biotech Infertility Services Products, Services and Solutions
    • 7.18.4 Caerus Biotech Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.19 InVitroCare
    • 7.19.1 InVitroCare Profile
    • 7.19.2 InVitroCare Main Business
    • 7.19.3 InVitroCare Infertility Services Products, Services and Solutions
    • 7.19.4 InVitroCare Infertility Services Revenue (US$ Million) & (2019-2024)
  • 7.20 INVO Bioscience
    • 7.20.1 INVO Bioscience Profile
    • 7.20.2 INVO Bioscience Main Business
    • 7.20.3 INVO Bioscience Infertility Services Products, Services and Solutions
    • 7.20.4 INVO Bioscience Infertility Services Revenue (US$ Million) & (2019-2024)
    • 7.20.5 INVO Bioscience Recent Developments

8 Industry Chain Analysis

  • 8.1 Infertility Services Industrial Chain
  • 8.2 Infertility Services Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
    • 10.1.2 Data Source
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Infertility Services Market Trends
  • Table 2. Infertility Services Market Drivers & Opportunity
  • Table 3. Infertility Services Market Challenges
  • Table 4. Infertility Services Market Restraints
  • Table 5. Global Infertility Services Revenue by Company (2019-2024) & (US$ Million)
  • Table 6. Global Infertility Services Revenue Market Share by Company (2019-2024)
  • Table 7. Key Companies Infertility Services Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Infertility Services Product Type
  • Table 9. Global Infertility Services Companies Market Concentration Ratio (CR5 and HHI)
  • Table 10. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infertility Services as of 2023)
  • Table 11. Mergers & Acquisitions, Expansion Plans
  • Table 12. Global Infertility Services Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 13. Global Infertility Services Sales Value by Type (2019-2024) & (US$ Million)
  • Table 14. Global Infertility Services Sales Value by Type (2025-2030) & (US$ Million)
  • Table 15. Global Infertility Services Sales Market Share in Value by Type (2019-2024)
  • Table 16. Global Infertility Services Sales Market Share in Value by Type (2025-2030)
  • Table 17. Global Infertility Services Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 18. Global Infertility Services Sales Value by Application (2019-2024) & (US$ Million)
  • Table 19. Global Infertility Services Sales Value by Application (2025-2030) & (US$ Million)
  • Table 20. Global Infertility Services Sales Market Share in Value by Application (2019-2024)
  • Table 21. Global Infertility Services Sales Market Share in Value by Application (2025-2030)
  • Table 22. Global Infertility Services Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
  • Table 23. Global Infertility Services Sales Value by Region (2019-2024) & (US$ Million)
  • Table 24. Global Infertility Services Sales Value by Region (2025-2030) & (US$ Million)
  • Table 25. Global Infertility Services Sales Value by Region (2019-2024) & (%)
  • Table 26. Global Infertility Services Sales Value by Region (2025-2030) & (%)
  • Table 27. Key Countries/Regions Infertility Services Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
  • Table 28. Key Countries/Regions Infertility Services Sales Value, (2019-2024) & (US$ Million)
  • Table 29. Key Countries/Regions Infertility Services Sales Value, (2025-2030) & (US$ Million)
  • Table 30. Ferring Pharmaceuticals Basic Information List
  • Table 31. Ferring Pharmaceuticals Description and Business Overview
  • Table 32. Ferring Pharmaceuticals Infertility Services Products, Services and Solutions
  • Table 33. Revenue (US$ Million) in Infertility Services Business of Ferring Pharmaceuticals (2019-2024)
  • Table 34. Merck Basic Information List
  • Table 35. Merck Description and Business Overview
  • Table 36. Merck Infertility Services Products, Services and Solutions
  • Table 37. Revenue (US$ Million) in Infertility Services Business of Merck (2019-2024)
  • Table 38. Jinxin Fertility Basic Information List
  • Table 39. Jinxin Fertility Description and Business Overview
  • Table 40. Jinxin Fertility Infertility Services Products, Services and Solutions
  • Table 41. Revenue (US$ Million) in Infertility Services Business of Jinxin Fertility (2019-2024)
  • Table 42. Vitrolife Basic Information List
  • Table 43. Vitrolife Description and Business Overview
  • Table 44. Vitrolife Infertility Services Products, Services and Solutions
  • Table 45. Revenue (US$ Million) in Infertility Services Business of Vitrolife (2019-2024)
  • Table 46. Mayo Clinic Basic Information List
  • Table 47. Mayo Clinic Description and Business Overview
  • Table 48. Mayo Clinic Infertility Services Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Infertility Services Business of Mayo Clinic (2019-2024)
  • Table 50. LIVZON Basic Information List
  • Table 51. LIVZON Description and Business Overview
  • Table 52. LIVZON Infertility Services Products, Services and Solutions
  • Table 53. Revenue (US$ Million) in Infertility Services Business of LIVZON (2019-2024)
  • Table 54. Abbott Basic Information List
  • Table 55. Abbott Description and Business Overview
  • Table 56. Abbott Infertility Services Products, Services and Solutions
  • Table 57. Revenue (US$ Million) in Infertility Services Business of Abbott (2019-2024)
  • Table 58. Monash IVF Basic Information List
  • Table 59. Monash IVF Description and Business Overview
  • Table 60. Monash IVF Infertility Services Products, Services and Solutions
  • Table 61. Revenue (US$ Million) in Infertility Services Business of Monash IVF (2019-2024)
  • Table 62. Monash IVF Recent Developments
  • Table 63. CARE facility Basic Information List
  • Table 64. CARE facility Description and Business Overview
  • Table 65. CARE facility Infertility Services Products, Services and Solutions
  • Table 66. Revenue (US$ Million) in Infertility Services Business of CARE facility (2019-2024)
  • Table 67. Theramex Basic Information List
  • Table 68. Theramex Description and Business Overview
  • Table 69. Theramex Infertility Services Products, Services and Solutions
  • Table 70. Revenue (US$ Million) in Infertility Services Business of Theramex (2019-2024)
  • Table 71. TriHealth Basic Information List
  • Table 72. TriHealth Description and Business Overview
  • Table 73. TriHealth Infertility Services Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Infertility Services Business of TriHealth (2019-2024)
  • Table 75. NMC Health Basic Information List
  • Table 76. NMC Health Description and Business Overview
  • Table 77. NMC Health Infertility Services Products, Services and Solutions
  • Table 78. Revenue (US$ Million) in Infertility Services Business of NMC Health (2019-2024)
  • Table 79. CooperSurgical Basic Information List
  • Table 80. CooperSurgical Description and Business Overview
  • Table 81. CooperSurgical Infertility Services Products, Services and Solutions
  • Table 82. Revenue (US$ Million) in Infertility Services Business of CooperSurgical (2019-2024)
  • Table 83. Irvine Scientific Basic Information List
  • Table 84. Irvine Scientific Description and Business Overview
  • Table 85. Irvine Scientific Infertility Services Products, Services and Solutions
  • Table 86. Revenue (US$ Million) in Infertility Services Business of Irvine Scientific (2019-2024)
  • Table 87. Virtus Health Basic Information List
  • Table 88. Virtus Health Description and Business Overview
  • Table 89. Virtus Health Infertility Services Products, Services and Solutions
  • Table 90. Revenue (US$ Million) in Infertility Services Business of Virtus Health (2019-2024)
  • Table 91. CinnaGen Basic Information List
  • Table 92. CinnaGen Description and Business Overview
  • Table 93. CinnaGen Infertility Services Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Infertility Services Business of CinnaGen (2019-2024)
  • Table 95. OB GYN Associates Basic Information List
  • Table 96. OB GYN Associates Description and Business Overview
  • Table 97. OB GYN Associates Infertility Services Products, Services and Solutions
  • Table 98. Revenue (US$ Million) in Infertility Services Business of OB GYN Associates (2019-2024)
  • Table 99. Caerus Biotech Basic Information List
  • Table 100. Caerus Biotech Description and Business Overview
  • Table 101. Caerus Biotech Infertility Services Products, Services and Solutions
  • Table 102. Revenue (US$ Million) in Infertility Services Business of Caerus Biotech (2019-2024)
  • Table 103. InVitroCare Basic Information List
  • Table 104. InVitroCare Description and Business Overview
  • Table 105. InVitroCare Infertility Services Products, Services and Solutions
  • Table 106. Revenue (US$ Million) in Infertility Services Business of InVitroCare (2019-2024)
  • Table 107. INVO Bioscience Basic Information List
  • Table 108. INVO Bioscience Description and Business Overview
  • Table 109. INVO Bioscience Infertility Services Products, Services and Solutions
  • Table 110. Revenue (US$ Million) in Infertility Services Business of INVO Bioscience (2019-2024)
  • Table 111. INVO Bioscience Recent Developments
  • Table 112. Key Raw Materials Lists
  • Table 113. Raw Materials Key Suppliers Lists
  • Table 114. Research Programs/Design for This Report
  • Table 115. Key Data Information from Secondary Sources
  • Table 116. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Infertility Services Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 2. Global Infertility Services Sales Value (2019-2030) & (US$ Million)
  • Figure 3. Infertility Services Report Years Considered
  • Figure 4. Global Infertility Services Players Revenue Ranking (2023) & (US$ Million)
  • Figure 5. The 5 Largest Companies in the World: Market Share by Infertility Services Revenue in 2023
  • Figure 6. The 10 Largest Companies in the World: Market Share by Infertility Services Revenue in 2023
  • Figure 7. Infertility Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 8. Assisted Reproductive Technology (ART) Picture
  • Figure 9. Infertility Drug Services Picture
  • Figure 10. Global Infertility Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
  • Figure 11. Global Infertility Services Sales Value Market Share by Type, 2023 & 2030
  • Figure 12. Global Infertility Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
  • Figure 13. Global Infertility Services Sales Value Market Share by Application, 2023 & 2030
  • Figure 14. North America Infertility Services Sales Value (2019-2030) & (US$ Million)
  • Figure 15. North America Infertility Services Sales Value by Country (%), 2023 VS 2030
  • Figure 16. Europe Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 17. Europe Infertility Services Sales Value by Country (%), 2023 VS 2030
  • Figure 18. Asia Pacific Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 19. Asia Pacific Infertility Services Sales Value by Region (%), 2023 VS 2030
  • Figure 20. South America Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 21. South America Infertility Services Sales Value by Country (%), 2023 VS 2030
  • Figure 22. Middle East & Africa Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 23. Middle East & Africa Infertility Services Sales Value by Country (%), 2023 VS 2030
  • Figure 24. United States Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 25. United States Infertility Services Sales Value by Type (%), 2023 VS 2030
  • Figure 26. United States Infertility Services Sales Value by Application (%), 2023 VS 2030
  • Figure 27. Europe Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 28. Europe Infertility Services Sales Value by Type (%), 2023 VS 2030
  • Figure 29. Europe Infertility Services Sales Value by Application (%), 2023 VS 2030
  • Figure 30. China Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 31. China Infertility Services Sales Value by Type (%), 2023 VS 2030
  • Figure 32. China Infertility Services Sales Value by Application (%), 2023 VS 2030
  • Figure 33. Japan Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 34. Japan Infertility Services Sales Value by Type (%), 2023 VS 2030
  • Figure 35. Japan Infertility Services Sales Value by Application (%), 2023 VS 2030
  • Figure 36. South Korea Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 37. South Korea Infertility Services Sales Value by Type (%), 2023 VS 2030
  • Figure 38. South Korea Infertility Services Sales Value by Application (%), 2023 VS 2030
  • Figure 39. Southeast Asia Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 40. Southeast Asia Infertility Services Sales Value by Type (%), 2023 VS 2030
  • Figure 41. Southeast Asia Infertility Services Sales Value by Application (%), 2023 VS 2030
  • Figure 42. India Infertility Services Sales Value, (2019-2030) & (US$ Million)
  • Figure 43. India Infertility Services Sales Value by Type (%), 2023 VS 2030
  • Figure 44. India Infertility Services Sales Value by Application (%), 2023 VS 2030
  • Figure 45. Infertility Services Industrial Chain
  • Figure 46. Bottom-up and Top-down Approaches for This Report
  • Figure 47. Data Triangulation
  • Figure 48. Key Executives Interviewed 119